Cetera Investment Advisers’s Pyxis Oncology PYXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6K | Buy |
28,760
+900
| +3% | +$990 | ﹤0.01% | 3991 |
|
|
2025
Q1 | $27.3K | Buy |
27,860
+1,000
| +4% | +$980 | ﹤0.01% | 3889 |
|
|
2024
Q4 | $41.9K | Buy |
26,860
+1,000
| +4% | +$1.56K | ﹤0.01% | 3660 |
|
|
2024
Q3 | $94.9K | Sell |
25,860
-2,250
| -8% | -$8.26K | ﹤0.01% | 3546 |
|
|
2024
Q2 | $93K | Sell |
28,110
-1,250
| -4% | -$4.14K | ﹤0.01% | 3522 |
|
|
2024
Q1 | $125K | Buy |
29,360
+8,998
| +44% | +$38.3K | ﹤0.01% | 3455 |
|
|
2023
Q4 | $36.7K | Buy |
20,362
+1,102
| +6% | +$1.98K | ﹤0.01% | 2178 |
|
|
2023
Q3 | $38.3K | Buy |
19,260
+1,000
| +5% | +$1.99K | ﹤0.01% | 2137 |
|
|
2023
Q2 | $46.7K | Buy |
+18,260
| New | +$46.7K | ﹤0.01% | 2126 |
|